MycoMed Technologies I Products to Prevent Infection

Recent News

/Recent News/

STTR Award Phase 2

Information sourced from NIH Research Portfolio Online Reporting Tools (RePORT) Easy-to-use, yet sensitive, diagnostic tests for early detection of invasive aspergillosis (IA) are still-unmet medical need, as IA continues causes morbidity and death in patients with compromised immunity. In Phase I, MycoMed Technologies LLC engineered a prototype lateral flow-based device (LFD) called AspUTest, and performance [...]

By | 2017-10-04T14:12:13+00:00 July 1st, 2017|

MII Award Phase 1

July 2015 Information sourced from TEDCO MII Award Maryland Innovation Initiative (MII) awards by TEDCO are given through the Innovation Commercialization Program, which provides funding to support the commercialization of qualified university technologies at two distinct stages: pre-commercial technology validation and commercialization planning (Phase I & 2 combined), and early-stage product development (company formation) (Phase [...]

By | 2017-10-04T14:12:31+00:00 July 1st, 2015|

SoMax Business Consulting Award

April 2015 2015 InvestMaryland Challenge: Winner, SoMax Business Consulting Award Maryland Department of Business and Economic Development (DBED) instituted the InvestMaryland Challenge, a national seed competition for qualified Maryland and non-Maryland early-stage businesses in the Life Sciences and Information Technology fields. In April 2015, the department, working with partners and sponsors, awarded a total of [...]

By | 2017-10-02T16:37:54+00:00 April 1st, 2015|

SBIR Phase I

Feb 2015 Information sourced from SBIR Source: SBIR Phase I Award The Federal Small Business Innovation Research (SBIR) drives the creation of new businesses and development of wide-ranging technologies; competitive R&D funding available under this program is intended exclusively for small high-tech companies with a goal of commercialization of innovative technologies in diverse fields, from [...]

By | 2017-10-02T16:32:43+00:00 February 1st, 2015|

STTR Award Phase 1

Information sourced from NIH Research Portfolio Online Reporting Tools (RePORT) Aspergillus polysaccharide antigens are excreted in urine in course of the lung disease, invasive pulmonary aspergillosis. About 200,000 people in the U.S. are at risk for this disease, which kills 40-80% of people who get it. Using a novel monoclonal antibody that detects Aspergillus antigens [...]

By | 2017-10-04T14:12:52+00:00 January 1st, 2015|